Clarivate Plc
NYSE:CLVT
Sector
Location
Market Cap
USD 2.59 B
Share Price
USD 3.86
Avg Daily Volume
5,192,154
Change (1 day)
1.31%
Change (1 year)
-32.16%
Change (YTD)
-24.02%
Clarivate Plc Depreciation And Amortization for the Trailing 12 Months (TTM) ending December 31, 2024: USD 727.00 M
Clarivate Plc Depreciation And Amortization is USD 727.00 M for the Trailing 12 Months (TTM) ending December 31, 2024, a 2.64% change year over year. Depreciation and amortization are expense that reduces the value of tangible and intangible assets over their useful lives for tax and reporting purposes.
-
Clarivate Plc Depreciation And Amortization for the Trailing 12 Months (TTM) ending December 31, 2023 was USD 708.30 M, a 0.80% change year over year.
-
Clarivate Plc Depreciation And Amortization for the Trailing 12 Months (TTM) ending December 31, 2022 was USD 702.70 M, a 30.66% change year over year.
-
Clarivate Plc Depreciation And Amortization for the Trailing 12 Months (TTM) ending December 31, 2021 was USD 537.82 M, a 77.41% change year over year.
-
Clarivate Plc Depreciation And Amortization for the Trailing 12 Months (TTM) ending December 31, 2020 was USD 303.15 M, a 51.17% change year over year.
StockViz
Competitors
Eli Lilly and Company
USD 625.65
LLY
-15.21
-2.37%
AbbVie Inc.
USD 198.05
ABBV
-0.81
-0.41%
Roche Holding AG
USD 318.77
RO.SW
-3.47
-1.08%
AstraZeneca PLC
USD 150.15
AZN.L
-2.01
-1.32%
Abbott Laboratories
USD 134.28
ABT
+2.22
1.68%
Novartis AG
USD 116.31
NOVN.SW
+1.16
1.00%
Novo Nordisk A/S
USD 50.40
NOVO-B.CO
+2.25
4.67%
Merck & Co., Inc.
USD 80.69
MRK
+0.32
0.40%
Thermo Fisher Scientific Inc.
USD 460.72
TMO
+5.98
1.31%
Amgen Inc.
USD 288.23
AMGN
+3.53
1.24%
Pfizer Inc.
USD 24.58
PFE
+0.35
1.44%
Gilead Sciences, Inc.
USD 119.41
GILD
+9.13
8.28%
Sanofi
USD 94.22
SAN.PA
-0.08
-0.08%
Vertex Pharmaceuticals Incorporated
USD 366.54
VRTX
-9.09
-2.42%
Bristol-Myers Squibb Company
USD 45.95
BMY
+0.59
1.30%
Key Data
| Date | Depreciation And Amortization | Dividends Paid | Common Stock Issued | Common Stock Repurchased |
|---|
Competitors
Eli Lilly and Company
USD 625.65
LLY
-15.21
-2.37%
AbbVie Inc.
USD 198.05
ABBV
-0.81
-0.41%
Roche Holding AG
USD 318.77
RO.SW
-3.47
-1.08%
AstraZeneca PLC
USD 150.15
AZN.L
-2.01
-1.32%
Abbott Laboratories
USD 134.28
ABT
+2.22
1.68%
Novartis AG
USD 116.31
NOVN.SW
+1.16
1.00%
Novo Nordisk A/S
USD 50.40
NOVO-B.CO
+2.25
4.67%
Merck & Co., Inc.
USD 80.69
MRK
+0.32
0.40%
Thermo Fisher Scientific Inc.
USD 460.72
TMO
+5.98
1.31%
Amgen Inc.
USD 288.23
AMGN
+3.53
1.24%
Pfizer Inc.
USD 24.58
PFE
+0.35
1.44%
Gilead Sciences, Inc.
USD 119.41
GILD
+9.13
8.28%
Sanofi
USD 94.22
SAN.PA
-0.08
-0.08%
Vertex Pharmaceuticals Incorporated
USD 366.54
VRTX
-9.09
-2.42%
Bristol-Myers Squibb Company
USD 45.95
BMY
+0.59
1.30%